Holen Sie sich die Stockscreener-App
14.11
8.87%
-1.39
Schlusskurs vom Vortag:
$15.50
Offen:
$15.24
24-Stunden-Volumen:
3.23M
Relative Volume:
1.75
Marktkapitalisierung:
$1.61B
Einnahmen:
-
Nettoeinkommen (Verlust:
$-284.08M
KGV:
-5.8224
EPS:
-2.4234
Netto-Cashflow:
$-234.65M
1W Leistung:
-12.21%
1M Leistung:
-10.37%
6M Leistung:
+140.63%
1J Leistung:
+19.00%
1-Tages-Spanne:
$14.11
$15.90
1-Wochen-Bereich:
$14.15
$16.75
52-Wochen-Spanne:
$3.72
$17.15
Cogent Biosciences Inc Stock (COGT) Company Profile
Firmenname
Cogent Biosciences Inc
Sektor
Branche
Telefon
617-945-5576
Adresse
275 WYMAN STREET, WALTHAM
Vergleichen Sie COGT mit anderen Aktien
| Aktien | Preis | Marktkapitalisierung | Umsatz | Nettogewinn | Free Cashflow | ENV |
|---|---|---|---|---|---|---|
COGT
Cogent Biosciences Inc
|
14.11 | 2.17B | 0 | -284.08M | -234.65M | -2.4234 |
|
VRTX
Vertex Pharmaceuticals Inc
|
426.65 | 109.22B | 11.39B | 3.64B | 3.50B | 13.99 |
|
REGN
Regeneron Pharmaceuticals Inc
|
629.87 | 67.50B | 14.25B | 4.58B | 3.88B | 41.77 |
|
ALNY
Alnylam Pharmaceuticals Inc
|
425.05 | 57.35B | 3.21B | 43.57M | 221.36M | 0.2405 |
|
ARGX
Argen X Se Adr
|
837.40 | 50.87B | 3.06B | 1.28B | 447.35M | 19.67 |
|
INSM
Insmed Inc
|
185.53 | 39.72B | 447.02M | -1.18B | -868.57M | -6.1812 |
Cogent Biosciences Inc Stock (COGT) Upgrades & Downgrades
| Datum | Aktion | Analytiker | Ratingänderung |
|---|---|---|---|
| 2025-10-16 | Eingeleitet | Stifel | Hold |
| 2025-09-03 | Eingeleitet | Raymond James | Strong Buy |
| 2025-03-07 | Eingeleitet | Scotiabank | Sector Outperform |
| 2024-12-11 | Herabstufung | Needham | Buy → Hold |
| 2024-02-26 | Herabstufung | Robert W. Baird | Outperform → Neutral |
| 2024-02-08 | Eingeleitet | Citigroup | Buy |
| 2023-12-11 | Herabstufung | Wedbush | Outperform → Neutral |
| 2023-12-08 | Eingeleitet | JP Morgan | Overweight |
| 2023-04-28 | Eingeleitet | Robert W. Baird | Outperform |
| 2023-03-27 | Fortgesetzt | H.C. Wainwright | Buy |
| 2022-12-14 | Eingeleitet | Needham | Buy |
| 2022-06-28 | Eingeleitet | Guggenheim | Buy |
| 2021-10-11 | Eingeleitet | H.C. Wainwright | Buy |
| 2021-06-09 | Fortgesetzt | Jefferies | Buy |
| 2020-12-23 | Eingeleitet | Piper Sandler | Overweight |
| 2020-10-14 | Eingeleitet | Ladenburg Thalmann | Buy |
Alle ansehen
Cogent Biosciences Inc Aktie (COGT) Neueste Nachrichten
HC Wainwright & Co. Reiterates Buy Rating for Cogent Biosciences (COGT) | COGT Stock News - GuruFocus
Will Cogent Biosciences Inc. stock maintain dividend yield2025 Price Targets & Smart Allocation Stock Reports - newser.com
What earnings revisions data tells us about Cogent Biosciences Inc.July 2025 News Drivers & Reliable Volume Spike Alerts - newser.com
How Cogent Biosciences Inc. stock benefits from tech adoption2025 Volatility Report & Stock Portfolio Risk Control - newser.com
Cogent Biosciences Spends Big As Drug Hopes Build - Finimize
Cogent Biosciences Reports Recent Business Highlights and Third Quarter 2025 Financial Results - Investing News Network
Cogent Biosciences, Inc. Reports Earnings Results for the Third Quarter and Nine Months Ended September 30, 2025 - MarketScreener
Cogent Biosciences (COGT): Anticipated Data Releases and Strategic Advancements - GuruFocus
Cogent Biosciences (COGT) Boosts Financial Position with Strong Cash Reserves - GuruFocus
Cogent Biosciences posts wider Q3 loss as costs rise - MarketScreener
Cogent Biosciences Announces Multiple Presentations at the 67th Annual American Society of Hematology (ASH) Meeting - The Manila Times
Cogent Biosciences (NASDAQ: COGT) expects Phase 3 PEAK Nov and APEX Dec readouts - Stock Titan
Cogent Bio (NASDAQ: COGT) to present NonAdvSM bezuclastinib, JAK2 V617F poster at ASH - Stock Titan
How Cogent Biosciences Inc. stock performs in high volatility marketsBear Alert & Momentum Based Trading Ideas - newser.com
What MACD and RSI say about Cogent Biosciences Inc.2025 Historical Comparison & Free Growth Oriented Trading Recommendations - newser.com
Why Cogent Biosciences Inc. stock remains resilient2025 Volatility Report & Growth-Oriented Investment Plans - newser.com
Candlestick signals on Cogent Biosciences Inc. stock todayJuly 2025 Momentum & Reliable Intraday Trade Plans - newser.com
What high frequency data says about Cogent Biosciences Inc.2025 Major Catalysts & Weekly Chart Analysis and Trade Guides - newser.com
Cogent Biosciences Inc.’s volatility index tracking explained2025 Fundamental Recap & AI Driven Stock Price Forecasts - newser.com
Is Cogent Biosciences Inc. stock a buy before product launches2025 Institutional Moves & Weekly Setup with High ROI Potential - newser.com
Will Cogent Biosciences Inc. stock benefit from upcoming earnings reportsMarket Risk Analysis & Real-Time Stock Entry Alerts - newser.com
Earnings visualization tools for Cogent Biosciences Inc.Quarterly Market Summary & Precise Trade Entry Recommendations - newser.com
How strong is Cogent Biosciences Inc. stock revenue growthBear Alert & Community Trade Idea Sharing - newser.com
Published on: 2025-11-02 00:56:21 - newser.com
Cogent Biosciences, Inc. (COGT) Analyst insights, Price targets and Recommendations - Yahoo! Finance UK
Can Cogent Biosciences Inc. stock rebound after recent weaknessMarket Performance Report & Long-Term Capital Growth Ideas - newser.com
Using R and stats models for Cogent Biosciences Inc. forecasting2025 Short Interest & Long-Term Growth Portfolio Plans - newser.com
Momentum divergence signals in Cogent Biosciences Inc. chart2025 Market Overview & Technical Pattern Based Signals - newser.com
Emerald Mutual Fund Advisers Trust Invests $6.43 Million in Cogent Biosciences, Inc. $COGT - MarketBeat
Full technical analysis of Cogent Biosciences Inc. stockJuly 2025 Reactions & Free Safe Capital Growth Stock Tips - newser.com
Published on: 2025-10-31 00:39:25 - newser.com
Finanzdaten der Cogent Biosciences Inc-Aktie (COGT)
Umsatz
Nettogewinn
Free Cashflow
ENV
1.37%
0.61%
In Yahoo öffnen
|
In Google öffnen
|
In Finviz öffnen
|
In MarketWatch öffnen
|
Öffnen Sie in EDGAR
|
Offen in Reuters
Kapitalisierung:
|
Volumen (24h):